OnCo
targetsTarget

IGF-1 receptor (IGF1R)

The IGF-1 receptor is a growth-factor receptor that many cancers use to survive; a decade of antibodies and kinase inhibitors against it failed in trials, a cautionary tale in oncology drug development.